(PharmaNewsWire.Com, January 29, 2021 ) According to the new market research report “Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) – Global Forecast” published by MarketsandMarkets™.
The Cell Dissociation Market is expected to reach USD 440.5 Million, at a CAGR of 12.8%
Growth Drivers in Depth:
# Increasing R&D Activities in Biopharmaceutical Companies # Favorable Funding Scenario for Cancer Research # Growth Opportunities in Emerging Markets
Latest Trends in Tissue Dissociation Market:
# Emergence of Advanced Tissue Dissociation Enzyme Products # Acceptance of Enzyme-Free Dissociation Products Over Enzymatic Dissociation Products
By product, the market segmented into enzymatic dissociation products, non-enzymatic dissociation products and instruments & accessories. The enzymatic dissociation products segment estimated to account for the largest market of the global cell dissociation market in 2018.
The end user segment includes pharmaceutical & biotechnology companies, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies segment is estimated to register the highest growth rate and largest market share during the forecast period. This is primarily attributed to increasing demand for enzymatic dissociation products and instruments by these end users.
The tissue segment includes connective tissue, epithelial tissue, and other tissue. Among all, the connective tissue accounted for the largest share of the market in 2017. This is primarily attributed to the increasing research on cancer.
The global cell dissociation market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period, however, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the increasing R&D investments and government funding for chronic disease research are driving the market in the region.
Leading Key Players in the Worldwide Industry:
Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US) have been identified as the key players in this market. These companies have broad product portfolios with comprehensive features. These leaders also have products for all end users in this market, a strong geographical presence, and a focus on continuous product innovation. Key industry players are focusing on the expansions of their presence to maintain and enhance their position in the cell dissociation market.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
